63083-4021 NDC - LOW MYCOSIS NOSODE

Drug Information

Product NDC: 63083-4021

Proprietary Name: Low Mycosis Nosode

Non Proprietary Name: Low Mycosis Nosode

Active Ingredient(s):
  • 6 [hp_X]/59mL ASPERGILLUS NIGER VAR. NIGER;
  • 6 [hp_X]/59mL AUREOBASIDIUM PULLULANS VAR. PULLUTANS;
  • 12 [hp_X]/59mL CANDIDA ALBICANS;
  • 12 [hp_X]/59mL CANDIDA TORRESII;
  • 12 [hp_X]/59mL CANDIDA TROPICALIS;
  • 6 [hp_X]/59mL GEOTRICHUM CANDIDUM;
  • 6 [hp_X]/59mL MUCOR RACEMOSUS;
  • 6 [hp_X]/59mL PENICILLIN G;
  • 6 [hp_X]/59mL PLEOSPORA HERBARUM;
  • 6 [hp_X]/59mL RHIZOPUS STOLONIFER;
  • 6 [hp_X]/59mL RHODOTORULA RUBRA


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Penicillin-class Antibacterial [EPC];
  • Penicillins [CS]

Labeler Information

Labeler Name: Professional Complementary Health Formulas
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:8/15/1984

Package Information

No. Package Code Package Description Billing Unit
163083-4021-259 mL in 1 BOTTLE, DROPPER (63083-4021-2)

NDC Record

Field Name Field Value Definition
PRODUCT NDC63083-4021The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELow Mycosis NosodeThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIX4021A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
NON PROPRIETARY NAMELow Mycosis NosodeThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE8/15/1984This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEProfessional Complementary Health FormulasName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; CANDIDA ALBICANS; CANDIDA TORRESII; CANDIDA TROPICALIS; GEOTRICHUM CANDIDUM; MUCOR RACEMOSUS; PENICILLIN G; PLEOSPORA HERBARUM; RHIZOPUS STOLONIFER; RHODOTORULA RUBRAAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 6; 12; 12; 12; 6; 6; 6; 6; 6; 6 
ACTIVE INGRED UNIT[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL 
PHARM CLASSESAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Penicillin-class Antibacterial [EPC], Penicillins [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023